Scholar Rock Holding Corp. (SRRK)
46.74
+0.45
(+0.97%)
USD |
NASDAQ |
Apr 28, 16:00
46.74
0.00 (0.00%)
After-Hours: 20:00
Scholar Rock Research and Development Expense (TTM) : 206.78M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Krystal Biotech, Inc. | 55.08M |
| Stoke Therapeutics, Inc. | 136.15M |
| Biogen, Inc. | 1.498B |
| Eli Lilly & Co. | 13.34B |
| Apellis Pharmaceuticals, Inc. | 295.85M |